DIGITAL NEWSROOM

Posts in: Exact Sciences News

November 20, 2023

Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing at ASCO^® 2023
June 20, 2023

Next Generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent specificity, Raising the Bar in Non-invasive Screening
June 01, 2023

EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK^® CERTIFICATION^™
May 09, 2023

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week^® Annual Meeting
April 12, 2023

EXACT SCIENCES PRESENTS ADVANCEMENTS IN CANCER DETECTION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH^® 2023 ANNUAL MEETING
February 21, 2023

Exact Sciences Announces Fourth Quarter 2022 Results
February 07, 2023

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
January 08, 2023

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results
January 07, 2023

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test
December 09, 2022

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
December 06, 2022

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022
October 24, 2022

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Multimedia

VIDEOS

PHOTOS

Choose your country

Patient login

Provider login

Choose your country

DIGITAL NEWSROOM

Posts in: Exact Sciences News

Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing at ASCO^® 2023

Next Generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent specificity, Raising the Bar in Non-invasive Screening

EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK^® CERTIFICATION^™

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week^® Annual Meeting

EXACT SCIENCES PRESENTS ADVANCEMENTS IN CANCER DETECTION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH^® 2023 ANNUAL MEETING

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Multimedia

Choose your country

Patient login

Provider login

Choose your country

DIGITAL NEWSROOM

Posts in: Exact Sciences News

Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing at ASCO® 2023

Next Generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent specificity, Raising the Bar in Non-invasive Screening

EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK® CERTIFICATION™

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting

EXACT SCIENCES PRESENTS ADVANCEMENTS IN CANCER DETECTION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH® 2023 ANNUAL MEETING

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Multimedia

Quick links

Products and services

Science

About

News and events

Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing at ASCO^® 2023

EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK^® CERTIFICATION^™

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week^® Annual Meeting

EXACT SCIENCES PRESENTS ADVANCEMENTS IN CANCER DETECTION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH^® 2023 ANNUAL MEETING

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022